Sunday, May 28, 2023

Email id: support@kenresearch.com, Contact Us : +91-9871552944

Home Business Singapore Contract Research Organization Market Size, Share Report Provides Potential Growth, Upcoming...

Singapore Contract Research Organization Market Size, Share Report Provides Potential Growth, Upcoming Demand and Industry Trends: Ken Research

The report titled “Singapore Contract Research Organization Market Outlook to 2022 – by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR” covers aspects such as CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR), by Number of Clinical Trials, by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others), and covering competitive landscape of major CRO companies including Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore CRO Market

Singapore CRO market has inclined at positive CAGR during 2013-2017. The market is majorly driven by patent expiration of main revenue-generating drugs, competition from the generic versions of branded drugs, and increasing research and development costs which have pushed pharmaceuticals manufacturers to look for strategies to cut costs and speed up the R&D processes. The manufacturers struggle to renew their pipelines while facing the challenges of efficient drug discovery which has propelled growth in the contract research outsourcing industry in Singapore. Further, the market is supported by best in class infrastructure for research, highly skilled workforce, Strong intellectual property (IP) and legal infrastructure and government support.

Request for Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=MTUwOTgw

Singapore Contract Research Outsourcing Market Size

Singapore CRO Market Segmentation

The CRO market includes revenue generated from Phase I, II, II, IV clinical trials, Pre-clinical market, data management, biostatistics, and central laboratory services, Pharmacovigilance, Bioanalytics and HEOR. Growing emphasis on translational research within pharmaceutical R&D due to the government’s commitment to scientific research has propelled the growth of pre-clinical market in Singapore. Early phase clinical trials such as Phase I and Phase II are rising rapidly owing to its small patient pool, strong legal and political system, world-class infrastructure and connectivity, and access to talents. Other services such as Pharmacovigilance has witnessed increase in revenue as their scope expanded from just addressing ADR (Adverse Drug Reaction) to risk management plans and also because it also complies with local and global regulations. Bioanalytics is growing, as high cost and risk has led pharmaceutical companies to outsource more of pre-clinical and early phase development services.

The oncology segment has accounted for more than half of the clinical trials in 2015. Major factor driving the oncology segment include rising cases of cancer, availability of government funding for research purposes, and growing expertise for cancer by CROs. Other major therapeutic segments include clinical pharmacology, gastroenterology & hepatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others.

Singapore CRO Market Competition Analysis

CRO market in Singapore is dominated by MNCs that are capitalizing on the increasing government support for clinical research and foreign investment. The number of clinical trials increased due to establishment of more clinical trial units and more patient participation that gives them the opportunity to access innovative experimental treatments that are not yet available in the market. The market is concentrated with top 10 companies occupying more than half of the overall market revenue. Major competition parameters include service portfolio and therapeutic areas covered by the Contract Research organization

Singapore Contract Research Organization Market Future Potential

Singapore CRO market is expected to grow at a positive CAGR during 2018-2022. The two most significant market growth drivers are the reduction of drug lag and cost. Other growth drivers such as vendor consolidation and increased outsourcing penetration will further augment the CRO market in Singapore.

Key Topics Covered in the Report:

  • Singapore CRO Market Size, 2013-2017
  • Singapore Phase I, Phase II, Phase II, Phase IV, Data Management, Pre-Clinical, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics, and HEOR Market Size, 2013-2017
  • Singapore CRO Market Segmentation(by Major Therapeutic Segments and by Phase of Clinical Trial)
  • Trends and Developments in Singapore CRO Market
  • Government Initiatives, Rules and Regulations in Singapore CRO Market
  • Singapore CRO Market Competitive Landscape
  • Singapore CRO Future Outlook and Projections, 2018-2022
  • Value Chain in Singapore CRO Industry

 Related Reports

Singapore Property Classifieds Market Outlook to 2025 – Driven by Consumer Preference and investments from VCs along with Exponential growth of smartphone penetration

Singapore International Remittance Market Outlook to 2023 – By Inbound & Outbound Remittance, By Banking and Non-Banking Channel, By Inflow & Outflow Remittance Corridors

Follow Us

LinkedIn | Instagram | Facebook | Twitter | YouTube

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

support@kenresearch.com

+91-9015378249

RELATED ARTICLES

The GCC Smart Home Market Depicted Strong Growth Over 2014-2019 with a CAGR of 19%. Will GCC continue this growth trajectory: Ken Research

Buy Now 1.The market is dominated by international brands creating a future possibility Global Technology adapted to Arab Needs. Other Challenges in Smart Home Market A smart...

Malaysia Cold Chain revenue to cross USD 100 Mn by 2026- What factors will help it reach there? Ken Research

Buy Now The Malaysia Cold Chain market is in the Growth stage. Next generation supply chains in Malaysia are utilizing robotics and automation to perform...

UAE Electric Vehicle Charging Equipment Market is aiming to reach USD 45 Mn by 2026. Will the market be able to achieve the target?...

Buy Now The EV Charging Equipment market OF UAE grew at a CAGR of ~42% from 2017 to 2021. The market is driven by increasing...

Most Popular

Global Nutraceuticals Market is forecasted to reach a market size of ~US$ 500 billion: Ken Research

Buy Now What Is the Size of Global Nutraceuticals Industry? Global Nutraceuticals market is growing at a CAGR of ~% in 2017-2022 and is expected to...

Global Epoxy Resin Market is expected to reach ~USD 15 Bn by 2028F: Ken Research

Buy Now Global Epoxy Resin Market By End-User The Global Epoxy Resin market is segmented by End-user into Building & Construction, Transportation, Consumer Goods, Wind Energy, Aerospace,...

The Global E-Learning market is anticipated to exceed USD 400 billion 2027 – Ken Research

Buy Now Competition Scenario in Global E-Learning Market In Global E-learning Market there are several players operating in the market, and top players account for a...

Global Network Telemetry Market is expected to record a positive CAGR of ~20% during the forecast period (2022-2028): Ken Research

Buy Now What Is the Size of Global Network Telemetry Industry? Global Network Telemetry market is growing at a CAGR of ~% in 2017-2022 and is...